Latest filing published 13 Oct 2026 for ORUKA THERAPEUTICS INC, €732k.
Arjun Agarwal discloses dealings in Oruka Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 13 July 2026 to 12 October 2026, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 13 October 2026 with a transaction (€732k) in Oruka Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations